CPAs are a lobbying priority for professional pharmacy organizations. In January 2012, the American Pharmacists Association (APhA) brought together a consortium of pharmacy, medical and care professionals from 12 countries to discuss the integration of CPAs into daily clinical practice.  The consortium published a white paper entitled ”Consortium Recommendations for Advancing Pharmacists” Patients Care Services and Collaborative Practice Agreements and summarized their recommendations.  b) In order for a pharmacist to enter into a community practice agreement, the pharmacist has: (1) a license to practice pharmacy in the community and currently work in pharmacy practice in the community; (2) have at least $1,000,000 in professional liability insurance; (3) have obtained a doctor with a degree in pharmacy or have 5 years of experience as a registered pharmacist or equivalent; (4) agree to devote part of its practice to the defined area of drug therapy that the pharmacist jointly manages; 5. agree to make at least 5 additional contact hours each year or 0.5 continuing education training units approved by the Board of Directors on DenpAlt`s practices, which are generally related to cooperation agreements; and (6) to participate in the medical assistance program run by the Secretary of Health and Human Services in accordance with Chapter 118E and Under XiX of the Social Security Act, as well as all federal events or waivers related to such a medical assistance program for limited purposes of designation and transmission of services under the program , where provisions for such participation are adopted in accordance with Chapter 118E. The term ”cooperation agreement” has also been referred to as a consultation agreement, a collaborative pharmacy practice agreement, a physician-pharmacist agreement, a permanent order or a permanent protocol, and a physician delegation.  A Collaborative Practice Agreement is a legal document in the United States that establishes a formal relationship between pharmacists (often clinical pharmacy specialists) and cooperating physicians, in order to create a legal and ethical basis for pharmacists involved in collaborative therapy management.   a ”cooperation agreement” (”cooperation agreement”), a written and signed agreement between a pharmacist with training and experience relevant to the scope of community practice and a supervisory physician who defines the community practice in which the pharmacist and the treating physician wish to engage.